From diverticulosis to complicated diverticular disease: Progression of myogenic alterations and oxidative imbalance
Lucia Pallotta,Annalinda Pisano,Rosa Vona,Martina Cappelletti,Maria Gemma Pignataro,Ivan Tattoli,Maria Antonietta Maselli,Mariarita Tarallo,Giovanni Casella,Roberto Caronna,Andrea Tancredi,Giorgia Burrelli Scotti,Giulia Scalese,Paola Matarrese,Carla Giordano,Carola Severi
DOI: https://doi.org/10.1111/nmo.14850
2024-06-25
Neurogastroenterology & Motility
Abstract:The different diverticular disease clinical phenotypes are part of a progressive process, characterized by a transmural oxidative imbalance and interstitial fibrosis with marked increase in muscle layer thickness, smooth muscle cell syncytium disarray and phenotypic switch, with chronic inflammation confined inside the mucosal layer. Background The natural history and pathophysiology of diverticular disease (DD) are still uncertain. An ex‐vivo human complicated DD (cDD) model has recently shown a predominant transmural oxidative imbalance. The present study aims to evaluate whether the previously described alterations may precede the symptomatic form of the disease. Methods Colonic surgical samples obtained from patients with asymptomatic diverticulosis (DIV), complicated DD, and controls were systematically and detailed morphologically and molecularly analyzed. Therefore, histologic, histomorphometric, immunohistochemical evaluation, and gene and protein expression analysis were performed to characterize colonic muscle changes and evaluate chronic inflammation, oxidative imbalance, and hypoxia. Functional muscle activity was tested on strips and isolated cells in response to contractile and relaxant agents. Key Results Compared with controls, DD showed a marketed increase in muscle layer thickness, smooth muscle cell syncytium disarray, and increased interstitial fibrosis; moreover, the observed features were more evident in the cDD group. These changes mainly affected longitudinal muscle and were associated with altered contraction‐relaxation dynamics and fibrogenic switch of smooth muscle cells. Chronic lymphoplasmacytic inflammation was primarily evident in the mucosa and spared the muscle. A transmural increase in carbonylated and nitrated proteins, with loss of antioxidant molecules, characterized both stages of DD, suggesting early oxidative stress probably triggered by recurrent ischemic events, more pronounced in cDD, where HIF‐1 was detected in both muscle and mucosa. Conclusion & Inferences The different DD clinical scenarios are part of a progressive process, with oxidative imbalance representing a new target in the management of DD.
gastroenterology & hepatology,neurosciences,clinical neurology